Insider Transactions in Q2 2021 at Allscripts Healthcare Solutions, Inc. (MDRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct |
50,000
-18.78%
|
$850,000
$17.54 P/Share
|
|
Jun 14
2021
|
Elizabeth Ann Altman |
SELL
Open market or private sale
|
Direct |
11,600
-28.7%
|
$197,200
$17.78 P/Share
|
|
Jun 14
2021
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
120,000
-7.14%
|
$2,040,000
$17.66 P/Share
|
|
Jun 08
2021
|
Michael Klayko Director |
SELL
Open market or private sale
|
Direct |
28,000
-42.05%
|
$504,000
$18.03 P/Share
|
|
Jun 04
2021
|
Michael Klayko Director |
SELL
Open market or private sale
|
Direct |
113,000
-62.92%
|
$2,034,000
$18.0 P/Share
|
|
May 25
2021
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+22.97%
|
-
|
|
May 25
2021
|
Mara G. Aspinall Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+11.16%
|
-
|
|
May 25
2021
|
Greg Garrison Execuitive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+8.78%
|
-
|
|
May 25
2021
|
Jonathan Judge |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+9.15%
|
-
|
|
May 25
2021
|
Michael Klayko Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+6.29%
|
-
|
|
May 25
2021
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+9.87%
|
-
|
|
May 25
2021
|
David D Stevens Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+6.18%
|
-
|
|
May 25
2021
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
12,056
+29.0%
|
-
|
|
May 04
2021
|
Richard J. Poulton CEO |
SELL
Open market or private sale
|
Direct |
75,000
-10.98%
|
$1,125,000
$15.69 P/Share
|
|
May 01
2021
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.83%
|
$64,515
$15.56 P/Share
|
|
Apr 02
2021
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,841
-0.78%
|
$27,615
$15.35 P/Share
|
|
Apr 01
2021
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,391
-1.0%
|
$35,865
$15.35 P/Share
|